Literature DB >> 11044826

Aortic angiosarcoma presenting with cutaneous metastasis: case report and review of the literature.

R J Rudd1, K P Fair, J W Patterson.   

Abstract

Aortic angiosarcoma is a rare malignancy. Clinical diagnosis is difficult, as the presenting symptoms mimic more common aortic lesions, particularly atherosclerosis. Dermatologists and dermatopathologists play a critical role in recognizing cutaneous metastases as a manifestation of this life-threatening tumor. We describe the fourth case of aortic angiosarcoma in the literature with initial presentation in the skin.

Entities:  

Mesh:

Year:  2000        PMID: 11044826     DOI: 10.1067/mjd.2000.101884

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

Review 1.  Hypersensitivity reactions to corticosteroids.

Authors:  Rani R Vatti; Fatima Ali; Suzanne Teuber; Christopher Chang; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

2.  Intimal sarcoma of the abdominal aorta and common iliac arteries presenting as epithelioid angiosarcoma of the skin: a case report.

Authors:  Shogo Tajima; Katsuyuki Hoshina; Tets Oushik; Kunihiro Shigematsu; Masashi Fukayama
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 3.  Cutaneous metastases of visceral tumours: a review.

Authors:  Dorothée Nashan; Marcel Lucas Müller; Markus Braun-Falco; Sebastian Reichenberger; Rolf-Markus Szeimies; Leena Bruckner-Tuderman
Journal:  J Cancer Res Clin Oncol       Date:  2008-06-17       Impact factor: 4.553

4.  [High-grade intimal sarcoma in an aneurysm of the infrarenal aorta].

Authors:  T Osei-Agyemang; J Geks; H-J Wagner; U Feek; B Gerdes
Journal:  Chirurg       Date:  2004-08       Impact factor: 0.955

5.  Femoral artery angiosarcoma presenting with distal embolization: report of a case.

Authors:  Abdo H Sattout; Madhuri V Deolekar; William F Tait; Gerard T Williams
Journal:  Surg Today       Date:  2008-05-31       Impact factor: 2.549

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.